Cowen And Company, LLC Dexcom Inc Transaction History

Cowen And Company, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$84.98 - $122.67 $317,825 - $458,785	-3,740 Reduced 61.36%	2,355 $266,000
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $465,353 - $574,027	6,095 New	6,095 $491,000
Q2 2022 Aug 05, 2022	SELL	$67.99 - $132.89 $106,336 - $207,839	-1,564 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $50,803 - $70,308	540 Added 52.73%	1,564 $800,000
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $132,986 - $166,727	1,024 New	1,024 $550,000
Q2 2021 Aug 13, 2021	SELL	$80.99 - $107.93 $289,215 - $385,418	-3,571 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$84.79 - $104.74 $302,785 - $374,026	3,571 New	3,571 $1.28 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.